Written By: Pharmacally Medical News Desk The European Medicines Agencys Committee for Medicinal Products for Human Use (CHMP) concluded its December 811, 2025 meeting with positive recommendations for seven new medicines and 12 extensions of indication for existing therapies
GI side effects, such as appetite changes, can sometimes affect bowel habits
Increases Energy Expenditure via Glucagon Receptor Activation A defining benefit of Retatrutide is its activation of the glucagon receptor, which is associated with increased energy expenditure and thermogenic activity
Semaglutide possesses a well-established cardioprotective profile, supported by landmark trials (SUSTAIN-6, PIONEER-6, and SELECT) that demonstrate significant reductions in MACE ( For tirzepatide, the SURPASS-CVOT trial provides robust contextual cardiovascular outcome data
Disturbances in GSH homeostasis have been implicated in neurodegenerative disorders, liver disease, cystic fibrosis, pulmonary and cardiovascular diseases, as well as the chronic age-related diseases and the aging process itself.Recent data also suggests it plays a role in metabolic and inflammatory diseases such as multiple sclerosis, the metabolic syndrome, and diabetes, at least in part by influencing the effect of multiple environmental toxins, an underappreciated yet surprisingly significant association
Limit is 1 Promotion redemption per Eligible Customer
